Refine
Has Fulltext
- yes (43)
Is part of the Bibliography
- yes (43)
Year of publication
Document Type
- Review (43) (remove)
Language
- English (43) (remove)
Keywords
- Psychologie (4)
- Rezension (4)
- Toxikologie (2)
- Activation induced cell death/AICD (1)
- Ameise (1)
- Anergy (1)
- Apoptosis (1)
- CNTF (1)
- Calcineurin (1)
- Erhard, C., & Keiling, T. / The Routledge Handbook of Phenomenology of Agency (1)
Institute
- Theodor-Boveri-Institut für Biowissenschaften (15)
- Neuphilologisches Institut - Moderne Fremdsprachen (5)
- Institut für Psychologie (4)
- Institut für Psychologie (bis Sept. 2007) (4)
- Physikalisches Institut (3)
- Institut für Klinische Neurobiologie (2)
- Institut für Molekulare Infektionsbiologie (2)
- Institut für Pharmakologie und Toxikologie (2)
- Institut für Evangelische Theologie und Religionspädagogik (1)
- Institut für Mathematik (1)
This paper presents an overview of the research on nonverbal communication that has appeared in the German-language literature during the past decade, and gives some treatment of its relationship to Ausdruckspsychologie. Empirical studies, recent theoretical issues, and methodological developments are discussed. - Although nonverbal communication often plays an essential role in diagnosis and treatment, it has been widely neglected in academic training for the past 20 years. This inconsistency may partly be due to the outright rejection of the classical Ausdruckspsychologie during the 1960's. In order to avoid the fate of Ausdruckspsychologie, it will be necessary to extend our knowledge of nonverbal communication by means of further methodological development and empirical investigation
This review is an attempt to highlight evidence that may implicate the endogenaus opioid system in the pathogenesis of hypertension in humans. The evidence raised includes biochemical, physiological, pharmacological, and behavioral studies con~ucted in in vitro andin vivo systems, experimental models of hypertension, and hornans with essential hypertension. While the compelling biochemical and pharmacological evidence in experimental animals clearly shows the presence of opioid peptides and their receptors in strategic sites of cardiovascular control and potent cardiovascular response to opioid peptides, opioid antagonists show no consistent blockade or reversal of hypertension in experimental animals or humans. One possible explanation for this phenomenon could be the vast redundancy in systems regulating blood pressure (i.e., the blockade ofone system stillleaves many other systerils fully able to rapidly offset the eliminated system). Regarding the opioid system, the situation is much more complex, since some opioid receptors (\(\mu\)-type) niediate pressor responses, while other receptors (\(\kappa\)type) mediate depressor responses. Therefore, nonselective opioid receptor antagonists (e.g., naloxone), which block both types ofreceptors, can be devoid ofany cardiovascular activity, while a selective \(\mu\)-receptor antagonist or a selective arid potent \(\kappa\)-receptor agonist may produce the desired antihypertensive elfect. A combination of both actions (i.e., a drug that is both \(\mu\)antagonist and a \(\kappa\)antagonist) might be even more advantageous. Until such compounds are developed, this hypothesis will be hard to prove.